Suppr超能文献

社区获得性肺炎的无创通气:来自 ICU 队列的失败结局和预测因素。

Non-Invasive Ventilation for Community-Acquired Pneumonia: Outcomes and Predictors of Failure from an ICU Cohort.

机构信息

General Intensive Care Unit, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.

出版信息

Medicina (Kaunas). 2023 Dec 30;60(1):81. doi: 10.3390/medicina60010081.

Abstract

: The use of non-invasive ventilation (NIV) for community-acquired pneumonia (CAP) remains controversial. NIV failure in the setting of acute hypoxemic respiratory failure is associated with increased mortality, highlighting the need for careful patient selection. : This is a retrospective observational cohort study. We included 140 patients with severe CAP, treated with either NIV or invasive mechanical ventilation (IMV) as their primary oxygenation strategy. The median PaO/FiO ratio and SOFA score upon ICU admission were 151 mmHg and 6, respectively. We managed 76% of patients with NIV initially and report an NIV success rate of 59%. Overall, the 28-day mortality was 25%, whilst for patients with NIV success, the mortality was significantly lower at 13%. In the univariate analysis, NIV failure was associated with the SOFA score (OR 1.33), the HACOR score (OR 1.14) and the presence of septic shock (OR 3.99). The SOFA score has an AUC of 0.75 for NIV failure upon ICU admission, whilst HACOR has an AUC of 0.76 after 2 h of NIV. : Our results suggest that a SOFA ≤ 4 and an HACOR ≤ 5 are reasonable thresholds to identify patients with severe CAP likely to benefit from NIV.

摘要

: 无创通气 (NIV) 在社区获得性肺炎 (CAP) 中的应用仍存在争议。急性低氧性呼吸衰竭时 NIV 失败与死亡率增加相关,这突出表明需要仔细选择患者。 : 这是一项回顾性观察队列研究。我们纳入了 140 例严重 CAP 患者,他们接受 NIV 或有创机械通气 (IMV) 作为主要氧合策略。入 ICU 时的 PaO/FiO 比值和 SOFA 评分中位数分别为 151mmHg 和 6。我们最初对 76%的患者进行了 NIV 治疗,报告 NIV 成功率为 59%。总体而言,28 天死亡率为 25%,而 NIV 成功的患者死亡率明显较低,为 13%。在单因素分析中,NIV 失败与 SOFA 评分(OR 1.33)、HACOR 评分(OR 1.14)和感染性休克的存在(OR 3.99)相关。SOFA 评分在入 ICU 时对 NIV 失败的 AUC 为 0.75,而 HACOR 在接受 NIV 治疗 2 小时后的 AUC 为 0.76。 : 我们的结果表明,SOFA ≤ 4 和 HACOR ≤ 5 是识别可能从 NIV 中获益的严重 CAP 患者的合理阈值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c0/10821344/5fbbe9f59209/medicina-60-00081-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验